Literature DB >> 16319919

ACNP Task Force report on SSRIs and suicidal behavior in youth.

J John Mann1, Graham Emslie, Ross J Baldessarini, William Beardslee, Jan A Fawcett, Frederick K Goodwin, Andrew C Leon, Herbert Y Meltzer, Neal D Ryan, David Shaffer, Karen D Wagner.   

Abstract

This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16319919     DOI： 10.1038/sj.npp.1300958

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


  35 in total

Review 1.  Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?

Authors:  Robert D Gibbons; J John Mann
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

2.  Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.

Authors:  Robert D Gibbons; C Hendricks Brown; Kwan Hur; John Davis; J John Mann
Journal:  Arch Gen Psychiatry       Date:  2012-06

3.  Manufacturing consensus.

Authors:  David Healy
Journal:  Cult Med Psychiatry       Date:  2006-06

4.  Use of psychotropic medications in Italian children and adolescents.

Authors:  Antonio Clavenna; Elisa Rossi; Marisa Derosa; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2006-10-07       Impact factor: 3.183

5.  Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.

Authors:  Kelly Posner; Maria A Oquendo; Madelyn Gould; Barbara Stanley; Mark Davies
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

6.  Association of suicide and antidepressant prescription rates in Japan, 1999-2003.

Authors:  Atsuo Nakagawa; Michael F Grunebaum; Steven P Ellis; Maria A Oquendo; Haruo Kashima; Robert D Gibbons; J John Mann
Journal:  J Clin Psychiatry       Date:  2007-06       Impact factor: 4.384

7.  Increase in US youth suicide rates 2004.

Authors:  Robert M Bossarte; Eric D Caine
Journal:  Inj Prev       Date:  2008-02       Impact factor: 2.399

Review 8.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

Review 9.  Smoking and suicide: a brief overview.

Authors:  John R Hughes
Journal:  Drug Alcohol Depend       Date:  2008-08-03       Impact factor: 4.492

10.  Mixed-effects Poisson regression analysis of adverse event reports: the relationship between antidepressants and suicide.

Authors:  Robert D Gibbons; Eisuke Segawa; George Karabatsos; Anup K Amatya; Dulal K Bhaumik; C Hendricks Brown; Kush Kapur; Sue M Marcus; Kwan Hur; J John Mann
Journal:  Stat Med       Date:  2008-05-20       Impact factor: 2.373
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.